Possible role of human herpesvirus 6 as a trigger of autoimmune disease

The Scientific World Journal

Volumn 2013, Issue , 2013, Pages

  Broccolo, Francesco ^a   Fusetti, Lisa ^b   Ceccherini Nelli, Luca ^b  

^a UNIVERSITY OF MILANO BICOCCA   (Italy)

^b UNIVERSITY OF PISA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CELL ANTIGEN; INTERLEUKIN 10; INTERLEUKIN 17; INTERLEUKIN 23; MEMBRANE COFACTOR PROTEIN; MYELIN BASIC PROTEIN; VIRUS DNA;

AMINO ACID SEQUENCE; APOPTOSIS; AUTOIMMUNE DISEASE; AUTOIMMUNITY; BLOOD BRAIN BARRIER; BRAIN BIOPSY; CD8+ T LYMPHOCYTE; CELL DEATH; CHRONIC INFLAMMATION; COMPLEMENT ACTIVATION; CONNECTIVE TISSUE DISEASE; CYTOKINE PRODUCTION; CYTOLYSIS; CYTOPATHOGENIC EFFECT; CYTOTOXIC T LYMPHOCYTE; DERMATOMYOSITIS; DISCOID LUPUS ERYTHEMATOSUS; DISEASE ASSOCIATION; ENVIRONMENTAL FACTOR; GENETIC PREDISPOSITION; GRAVES DISEASE; HASHIMOTO DISEASE; HEREDITY; HUMAN; HUMAN HERPESVIRUS 6; IMMUNOHISTOCHEMISTRY; IMMUNOSUPPRESSIVE TREATMENT; IMMUNOSURVEILLANCE; KIKUCHI DISEASE; MOLECULAR MIMICRY; MULTIPLE SCLEROSIS; NERVOUS SYSTEM INFLAMMATION; OLIGODENDROGLIA; PHENOTYPE; PREVALENCE; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; REVIEW; RHEUMATOID ARTHRITIS; SJOEGREN SYNDROME; SYSTEMIC LUPUS ERYTHEMATOSUS; VIRUS LOAD; WHITE MATTER LESION; PHYSIOLOGY; VIROLOGY;

HUMAN HERPESVIRUS 6;

AUTOIMMUNE DISEASES; HERPESVIRUS 6, HUMAN; HUMANS;

EID: 84887429427     PISSN: None     EISSN: 1537744X     Source Type: Journal    
DOI: 10.1155/2013/867389     Document Type: Review

References (70)

1. Challoner P. B., Smith K. T., Parker J. D., Plaque-associated expression of human herpes virus 6 in multiple sclerosis. Proceedings of the National Academy of Sciences of the United States of America 1995 92 7440 77444
2. Soldan S. S., Berti R., Salem N., Secchiero P., Flamand L., Calabresi P. A., Brennan M. B., Maloni H. W., Mcfarland H. F., Lin H.-C., Patnaik M., Jacobson S., Association of human herpes virus 6 (HHV-6) with multiple sclerosis: increased IgM response to HHV-6 early antigen and detection of serum HHV-6 DNA. Nature Medicine 1997 3 12 1394 1397 2-s2.0-17444453701 10.1038/nm1297-1394 (Pubitemid 28011041)
3. Fillet A.-M., Lozeron P., Agut H., Lyon-Caen O., Liblau R., Coates A. R. M., Bell J., Jacobson S., Soldan S. S., Berti R., HHV-6 and multiple sclerosis. Nature Medicine 1998 4 5 537 538 2-s2.0-0031808571
4. Coates A. R., Bell J., HHV-6 andmultiple sclerosis. Nature Medicine 1998 4 5 537 538
5. Ablashi D. V., Lapps W., Kaplan M., Whitman J. E., Richert J. R., Pearson G. R., Human Herpesvirus-6 (HHV-6) infection in multiple sclerosis: a preliminary report. Multiple Sclerosis 1998 4 6 490 496 2-s2.0-0032441219 (Pubitemid 29042156)
6. Friedman J. E., Lyons M. J., Cu G., Ablashl D. V., Whitman J. E., Edgar M., Koskiniemi M., Vaheri A., Zabriskie J. B., The association of the human herpesvirus-6 and MS. Multiple Sclerosis 1999 5 5 355 362 2-s2.0-0032728026 (Pubitemid 29505051)
7. Voumvourakis K. I., Kitsos D. K., Tsiodras S., Petrikkos G., Stamboulis E., Human herpesvirus 6 infection as a trigger of multiple sclerosis. Mayo Clinic Proceedings 2010 85 11 1023 1030
8. Krueger G. R. F., Sander C., Hoffmann A., Barth A., Koch B., Braun M., Isolation of human herpesvirus-6 (HHV-6) from patients with collagen vascular diseases. In Vivo 1991 5 3 217 225 2-s2.0-0025848879
9. Hoffmann A., Kirn E., Kuerten A., Sander C., Krueger G. R. F., Ablashi D. V., Active human herpesvirus-6 (HHV-6) infection associated with Kikuchi-Fujimoto disease and systemic lupus erythematosus (SLE). In Vivo 1991 5 3 265 269 2-s2.0-0025753508
10. Broccolo F., Drago F., Paolino S., Cassina G., Gatto F., Fusetti L., Matteoli B., Zaccaria E., Parodi A., Lusso P., Ceccherini-Nelli L., Malnati M. S., Reactivation of human herpesvirus 6 (HHV-6) infection in patients with connective tissue diseases. Journal of Clinical Virology 2009 46 1 43 46 2-s2.0-67949099185 10.1016/j.jcv.2009.05.010
11. Broccolo F., Drago F., Cassina G., Selective reactivation of human herpesvirus 6 in patients with autoimmune connective tissue diseases. Journal of Medical Virology 2013 85 11 1925 1934
12. Caselli E., Zatelli M. C., Rizzo R., Virologic and immunologic evidence supporting an association between HHV-6 and Hashimoto's thyroiditis. PLOS Pathogens 2012 8 10 100295
13. Ranger-Rogez S., Vidal E., Liozon F., Denis F., Primary Sjogren's syndrome and antibodies to human herpesvirus type 6. Clinical Infectious Diseases 1994 19 6 1159 1160 2-s2.0-0028173097 (Pubitemid 24380039)
14. Boccara O., Lesage F., Regnault V., Lasne D., Dupic L., Bourdon-Lanoy E., Pannier S., Fraitag S., Audat F., Lecompte T., Hubert P., Bodemer C., Nonbacterial purpura fulminans and severe autoimmune acquired protein S deficiency associated with human herpesvirus-6 active replication. British Journal of Dermatology 2009 161 1 181 183 2-s2.0-67649908727 10.1111/j.1365-2133.2009.09264.x
15. Potenza L., Luppi M., Barozzi P., Rossi G., Cocchi S., Codeluppi M., Pecorari M., Masetti M., Di Benedetto F., Gennari W., Portolani M., Gerunda G. E., Lazzarotto T., Landini M. P., Schulz T. F., Torelli G., Guaraldi G., HHV-6A in syncytial giant-cell hepatitis. The New England Journal of Medicine 2008 359 6 593 602 2-s2.0-49249137995 10.1056/NEJMoa074479
16. Grima P., Chiavaroli R., Calabrese P., Tundo P., Severe hepatitis with autoimmune features following a HHV-6: a case report. Cases Journal 2008 1, article 110
17. Yagasaki H., Kato M., Shimizu N., Shichino H., Chin M., Mugishima H., Autoimmune hemolytic anemia and autoimmune neutropenia in a child with erythroblastopenia of childhood (TEC) caused by human herpesvirus-6 (HHV-6). Annals of Hematology 2011 90 7 851 852 2-s2.0-79960280196 10.1007/s00277-010- 1095-x
18. McClain M. T., Heinlen L. D., Dennis G. J., Roebuck J., Harley J. B., James J. A., Early events in lupus humoral autoimmunity suggest initiation through molecular mimicry. Nature Medicine 2005 11 1 85 89 2-s2.0-13444287958 10.1038/nm1167 (Pubitemid 40215842)
19. Lunardi C., Bason C., Corrocher R., Puccetti A., Induction of endothelial cell damage by hCMV molecular mimicry. Trends in Immunology 2005 26 1 19 24 2-s2.0-11144241470 10.1016/j.it.2004.10.009 (Pubitemid 40051988)
20. Mackay I. R., Leskovsek N. V., Rose N. R., Cell damage and autoimmunity: a critical appraisal. Journal of Autoimmunity 2008 30 1-2 5 11 2-s2.0-38049078520 10.1016/j.jaut.2007.11.009
21. Hafler D. A., Multiple sclerosis. The Journal of Clinical Investigation 2004 113 6 788 794 2-s2.0-2142662186 10.1172/JCI200421357 (Pubitemid 38544133)
22. Donati D., Martinelli E., Cassiani-Ingoni R., Ahlqvist J., Hou J., Major E. O., Jacobson S., Variant-specific tropism of human herpesvirus 6 in human astrocytes. Journal of Virology 2005 79 15 9439 9448 2-s2.0-22544434363 10.1128/JVI.79.15.9439-9448.2005 (Pubitemid 41022288)
23. Akhyani N., Berti R., Brennan M. B., Soldan S. S., Eaton J. M., McFarland H. F., Jacobson S., Tissue distribution and variant characterization of human herpesvirus (HHV)-6: increased prevalence of HHV-6A in patients with multiple sclerosis. Journal of Infectious Diseases 2000 182 5 1321 1325 2-s2.0-0033791290 10.1086/315893
24. Sanders V. J., Felisan S., Waddell A., Tourtellotte W. W., Detection of Herpesviridae in postmortem multiple sclerosis brain tissue and controls by polymerase chain reaction. Journal of NeuroVirology 1996 2 4 249 258 2-s2.0-0029814261 (Pubitemid 26285269)
25. Kim J.-S., Lee K.-S., Park J.-H., Kim M.-Y., Shin W.-S., Detection of human herpesvirus 6 variant A in peripheral blood mononuclear cells from multiple sclerosis patients. European Neurology 2000 43 3 170 173 2-s2.0-0034026283 (Pubitemid 30189539)
26. Chapenko S., Millers A., Nora Z., Logina I., Kukaine R., Murovska M., Correlation between HHV-6 reactivation and multiple sclerosis disease activity. Journal of Medical Virology 2003 69 1 111 117 2-s2.0-0037211715 10.1002/jmv.10258 (Pubitemid 35403662)
27. Opsahl M. L., Kennedy P. G. E., Early and late HHV-6 gene transcripts in multiple sclerosis lesions and normal appearing white matter. Brain 2005 128 3 516 527 2-s2.0-15044359537 10.1093/brain/awh390 (Pubitemid 40380187)
28. Rotola A., Merlotti I., Caniatti L., Caselli E., Granieri E., Tola M. R., Di Luca D., Cassai E., Human herpesvirus 6 infects the central nervous system of multiple sclerosis patients in the early stages of the disease. Multiple Sclerosis 2004 10 4 348 354 2-s2.0-4344618797 10.1191/1352458504ms1045oa (Pubitemid 39117328)
29. Goodman A. D., Mock D. J., Powers J. M., Baker J. V., Blumberg B. M., Human herpesvirus 6 genome and antigen in acute multiple sclerosis lesions. Journal of Infectious Diseases 2003 187 9 1365 1376 2-s2.0-0037988716 10.1086/368172 (Pubitemid 36549681)
30. Wilborn F., Schmidt C. A., Brinkmann V., Jendroska K., Oettle H., Siegert W., A potential role for human herpesvirus type 6 in nervous system disease. Journal of Neuroimmunology 1994 49 1-2 213 214 2-s2.0-0028324394 10.1016/0165-5728(94)90198-8 (Pubitemid 24071771)
31. Álvarez-Lafuente R., De Las Heras V., Bartolomé M., Picazo J. J., Arroyo R., Relapsing-remitting multiple sclerosis and human herpesvirus 6 active infection. Archives of Neurology 2004 61 10 1523 1527 2-s2.0-5344263747 10.1001/archneur.61.10.1523 (Pubitemid 39350262)
32. Simpson S., Taylor B., Dwyer D. E., Anti-HHV-6 IgG titer significantly predicts subsequent relapse risk in multiple sclerosis. Multiple Sclerosis 2012 18 799 806
33. Martin C., Enbom M., Söderström M., Fredrikson S., Dahl H., Lycke J., Bergström T., Linde A., Absence of seven human herpesviruses, including HHV-6, by polymerase chain reaction in CSF and blood from patients with multiple sclerosis and optic neuritis. Acta Neurologica Scandinavica 1997 95 5 280 283 2-s2.0-0030924266 (Pubitemid 27214477)
34. Mirandola P., Stefan A., Brambilla E., Campadelli-Fiume G., Grimaldi L. M. E., Absence of human herpesvirus 6 and 7 from spinal fluid and serum of multiple sclerosis patients. Neurology 1999 53 6 1367 1368 2-s2.0-0032860267 (Pubitemid 29480112)
35. Tejada-Simon M. V., Zang Y. C. Q., Hong J., Rivera V. M., Zhang J. Z., Cross-reactivity with myelin basic protein and human herpesvirus-6 in multiple sclerosis. Annals of Neurology 2003 53 2 189 197 2-s2.0-0037309220 10.1002/ana.10425 (Pubitemid 36164000)
36. Dietrich J., Blumberg B. M., Roshal M., Baker J. V., Hurley S. D., Mayer-Pröschel M., Mock D. J., Infection with an endemic human herpesvirus disrupts critical glial precursor cell properties. Journal of Neuroscience 2004 24 20 4875 4883 2-s2.0-2442707812 10.1523/JNEUROSCI.5584-03.2004 (Pubitemid 38668212)
37. Cirone M., Cuomo L., Zompetta C., Ruggieri S., Frati L., Faggioni A., Ragona G., Human herpesvirus 6 and multiple sclerosis: a study of T cell cross-reactivity to viral and myelin basic protein antigens. Journal of Medical Virology 2002 68 2 268 272 2-s2.0-0036779194 10.1002/jmv.10190
38. Cheng W., Ma Y., Gong F., Hu C., Qian L., Huang Q., Yu Q., Zhang J., Chen S., Liu Z., Chen X., Zhou T., Zhang D., Cross-reactivity of autoreactive T cells with MBP and viral antigens in patients with MS. Frontiers in Bioscience 2012 17 5 1648 1658 2-s2.0-84859241576 10.2741/4010
39. Santoro F., Kennedy P. E., Locatelli G., Malnati M. S., Berger E. A., Lusso P., CD46 is a cellular receptor for human herpesvirus 6. Cell 1999 99 7 817 827 2-s2.0-0033598990 (Pubitemid 30017651)
40. Tang H., Serada S., Kawabata A., Ota M., Hayashi E., Naka T., Yamanishi K., Mori Y., CD134 is a cellular receptor specific for human herpesvirus-6B entry. Proceedings of the National Academy of Sciences of the United States of America 2013 110 9096 9099
41. Assem M. M., Gad W. H., El-Sharkawy N. M., El-Rouby M. N., Ghaleb F. M., Tarek H., Kamel A. M., Prevalence of anti human herpes virus-6 IgG and its receptor in acute leukemia (membrane cofactor protein: MCP, CD46). Journal of the Egyptian National Cancer Institute 2005 17 1 29 34 2-s2.0-39049187536
42. Dhiman N., Jacobson R. M., Poland G. A., Measles virus receptors: SLAM and CD46. Reviews in Medical Virology 2004 14 4 217 229 2-s2.0-3042746923 10.1002/rmv.430 (Pubitemid 38879814)
43. Cuida M., Legler D. W., Eidsheim M., Jonsson R., Complement regulatory proteins in the salivary glands and saliva of Sjogren's syndrome patients and healthy subjects. Clinical and Experimental Rheumatology 1997 15 6 615 623 2-s2.0-0030825977 (Pubitemid 27501647)
44. Kawano M., Seya T., Koni I., Mabuchi H., Elevated serum levels of soluble membrane cofactor protein (CD46, MCP) in patients with systemic lupus erythematosus (SLE). Clinical and Experimental Immunology 1999 116 3 542 546 2-s2.0-0033061966 10.1046/j.1365-2249.1999.00917.x (Pubitemid 29258109)
45. Soldan S. S., Fogdell-Hahn A., Brennan M. B., Mittleman B. B., Ballerini C., Massacesi L., Seya T., McFarland H. F., Jacobson S., Elevated serum and cerebrospinal fluid levels of soluble human herpesvirus type 6 cellular receptor, membrane cofactor protein, in patients with multiple sclerosis. Annals of Neurology 2001 50 4 486 493 2-s2.0-0034796166 10.1002/ana.1135 (Pubitemid 32938893)
46. Hammarstedt M., Ahlqvist J., Jacobson S., Garoff H., Fogdell-Hahn A., Purification of infectious human herpesvirus 6A virions and association of host cell proteins. Virology Journal 2007 4, article 101 2-s2.0-37549055125 10.1186/1743-422X-4-101
47. Fogdell-Hahn A., Soldan S. S., Shue S., Akhyani N., Refai H., Ahlqvist J., Jacobson S., Co-purification of soluble membrane cofactor protein (CD46) and human herpesvirus 6 variant A genome in serum from multiple sclerosis patients. Virus Research 2005 110 1-2 57 63 2-s2.0-17444375727 10.1016/j.virusres.2005. 01.005 (Pubitemid 40544546)
48. Alvarez-Lafuente R., García-Montojo M., De las Heras V., Bartolomé M., Arroyo R., Clinical parameters and HHV-6 active replication in relapsing-remitting multiple sclerosis patients. Journal of Clinical Virology 2006 37 S24 S26 2-s2.0-34548015191 10.1016/S1386-6532(06)70007-5
49. Shusta E. V., Zhu C., Boado R. J., Pardridge W. M., Subtractive expression cloning reveals high expression of CD46 at the blood-brain barrier. Journal of Neuropathology and Experimental Neurology 2002 61 7 597 604 2-s2.0-0036295091 (Pubitemid 34721464)
50. Astier A., Trescol-Biémont M.-C., Azocar O., Lamouille B., Rabourdin-Combe C., Cutting edge: CD46, a new costimulatory molecule for T cells, that induces p120(CBL) and LAT phosphorylation. Journal of Immunology 2000 164 12 6091 6095 2-s2.0-0343953444 (Pubitemid 30408783)
51. Astier A. L., Hafler D. A., Abnormal Tr1 differentiation in multiple sclerosis. Journal of Neuroimmunology 2007 191 1-2 70 78 2-s2.0-35848964590 10.1016/j.jneuroim.2007.09.018 (Pubitemid 350061001)
52. Haas J., Hug A., Viehöver A., Fritzsching B., Falk C. S., Filser A., Vetter T., Milkova L., Korporal M., Fritz B., Storch-Hagenlocher B., Krammer P. H., Suri-Payer E., Wildemann B., Reduced suppressive effect of CD4+CD25high regulatory T cells on the T cell immune response against myelin oligodendrocyte glycoprotein in patients with multiple sclerosis. European Journal of Immunology 2005 35 11 3343 3352 2-s2.0-27944499757 10.1002/eji.200526065 (Pubitemid 41672538)
53. Viglietta V., Baecher-Allan C., Weiner H. L., Hafler D. A., Loss of functional suppression by CD4+ CD25+ regulatory T cells in patients with multiple sclerosis. Journal of Experimental Medicine 2004 199 7 971 979 2-s2.0-1842732224 10.1084/jem.20031579 (Pubitemid 38481088)
54. Marie J. C., Astier A. L., Rivailler P., Rabourdin-Combe C., Wild T. F., Horvat B., Linking innate and acquired immunity: divergent role of CD46 cytoplasmic domains in T cell-induced inflammation. Nature Immunology 2002 3 7 659 666 2-s2.0-0036305568 10.1038/ni810 (Pubitemid 34752475)
55. Kemper C., Chan A. C., Green J. M., Brett K. A., Murphy K. M., Atkinson J. P., Activation of human CD4+ cells with CD3 and CD46 induces a T-regulatory cell 1 phenotype. Nature 2003 421 6921 388 392 2-s2.0-0347895101 10.1038/nature01315 (Pubitemid 36157938)
56. Astier A. L., Meiffren G., Freeman S., Hafler D. A., Alterations in CD46-mediated Tr1 regulatory T cells in patients with multiple sclerosis. The Journal of Clinical Investigation 2006 116 12 3252 3257 2-s2.0-33845302957 10.1172/JCI29251 (Pubitemid 44878639)
57. Vaknin-Dembinsky A., Murugaiyan G., Hafler D. A., Astier A. L., Weiner H. L., Increased IL-23 secretion and altered chemokine production by dendritic cells upon CD46 activation in patients with multiple sclerosis. Journal of Neuroimmunology 2008 195 1-2 140 145 2-s2.0-41949084341 10.1016/j.jneuroim.2008. 01.002
58. Yao K., Graham J., Akahata Y., Oh U., Jacobson S., Mechanism of neuroinflammation: enhanced cytotoxicity and IL-17 production via CD46 binding. Journal of Neuroimmune Pharmacology 2010 5 3 469 478 2-s2.0-77955982744 10.1007/s11481-010-9232-9
59. Hamamdzic D., Kasman L. M., LeRoy E. C., The role of infectious agents in the pathogenesis of systemic sclerosis. Current Opinion in Rheumatology 2002 14 6 694 698 2-s2.0-0036838983 10.1097/00002281-200211000-00011 (Pubitemid 35191558)
60. Sekigawa I., Nawata M., Seta N., Yamada M., Iida N., Hashimoto H., Cytomegalovirus infection in patients with systemic lupus erythematosus. Clinical and Experimental Rheumatology 2002 20 4 559 564 2-s2.0-0035988642 (Pubitemid 34846636)
61. Lehmann H. W., von Landenberg P., Modrow S., Parvovirus B19 infection and autoimmune disease. Autoimmunity Reviews 2003 2 4 218 223 2-s2.0-0038387869 10.1016/S1568-9972(03)00014-4 (Pubitemid 36793946)
62. Harley B. J., Harley I. T. W., Guthridge J. M., James J. A., The curiously suspicious: a role for Epstein-Barr virus in lupus. Lupus 2006 15 11 768 777 2-s2.0-34250662605 10.1177/0961203306070009
63. Grossman C., Dovrish Z., Shoenfeld Y., Amital H., Do infections facilitate the emergence of systemic sclerosis? Autoimmunity Reviews 2011 10 5 244 247 2-s2.0-79952040993 10.1016/j.autrev.2010.09.010
64. Hueston W. J., Treatment of hypothyroidism. American Family Physician 2001 64 10 1717 1724 2-s2.0-0035890761 (Pubitemid 33095867)
65. Staii A., Mirocha S., Todorova-Koteva K., Glinberg S., Jaume J. C., Hashimoto thyroiditis is more frequent than expected when diagnosed by cytology which uncovers a pre-clinical state. Thyroid Research 2010 3 1, article 11 2-s2.0-78651090542 10.1186/1756-6614-3-11
66. Mori K., Yoshida K., Viral infection in induction of Hashimoto's thyroiditis: a key player or just a bystander? Current Opinion in Endocrinology, Diabetes and Obesity 2010 17 5 418 424 2-s2.0-77956267713 10.1097/MED. 0b013e32833cf518
67. Scotet E., Peyrat M.-A., Saulquin X., Retiere C., Couedel C., Davodeau F., Dulphy N., Toubert A., Bignon J.-D., Lim A., Vie H., Hallet M.-M., Liblau R., Weber M., Berthelot J.-M., Houssaint E., Bonneville M., Frequent enrichment for CD8 T cells reactive against common herpes viruses in chronic inflammatory lesions: towards a reassessment of the physiopathological significance of T cell clonal expansions found in autoimmune inflammatory processes. European Journal of Immunology 1999 29 3 973 985 2-s2.0-0032985551 (Pubitemid 29119078)
68. Thomas D., Liakos V., Michou V., Kapranos N., Kaltsas G., Tsilivakos V., Tsatsoulis A., Detection of herpes virus DNA in post-operative thyroid tissue specimens of patients with autoimmune thyroid disease. Experimental and Clinical Endocrinology and Diabetes 2008 116 1 35 39 2-s2.0-39449092195 10.1055/s-2007-956171 (Pubitemid 351270906)
69. Khoury E. L., Pereira L., Greenspan F. S., Induction of HLA-DR expression on thyroid follicular cells by cytomegalovirus infection in vitro: evidence for a dual mechanism of induction. American Journal of Pathology 1991 138 5 1209 1223 2-s2.0-0025845699
70. Fan J.-L., Desai R. K., Dallas J. S., Wagle N. M., Seetharamaiah G. S., Prabhakar B. S., High frequency of B cells capable of producing anti-thyrotropin receptor antibodies in patients with Graves' disease. Clinical Immunology and Immunopathology 1994 71 1 69 74 2-s2.0-0028351237 10.1006/clin.1994.1053 (Pubitemid 24126601)